Unmanaged care: the need to regulate new reproductive technologies in the United States.
D026683:Advisory Committees; D001290:Attitude; D001315:Australia; D002170:Canada; D002648:Child; D016265:Conflict of Interest; D030881:Disclosure; D004467:Economics; D005053:Eugenics; D005060:Europe; D005249:Fees and Charges; D005307:Fertilization in Vitro; D005610:Freedom; D005854:Germ Cells; D033161:Government Regulation; D017408:Guidelines as Topic; D006268:Health Facilities; D006805:Human Experimentation; D006801:Humans; D007221:Industry; D007258:Informed Consent; D007391:International Cooperation; D038622:Internationality; D008318:Malpractice; D018587:Oocyte Donation; D005791:Patient Care; D010820:Physicians; D011050:Policy Making; D011057:Politics; D028743:Professional Misconduct; D011640:Public Policy; D011787:Quality of Health Care; D012015:Reference Standards; D012098:Reproduction; D027724:Reproductive Techniques, Assisted; D012306:Risk; D018570:Risk Assessment; D015871:Scientific Misconduct; D012926:Social Control, Formal; D012927:Social Control, Informal; D012935:Social Justice; D012941:Social Responsibility; D012946:Social Welfare; D012952:Societies; D014019:Tissue Donors; D016896:Treatment Outcome; D006113:United Kingdom; D014481:United States; D014947:Wounds and Injuries
Analytical Approach; Genetics and Reproduction; Legal Approach; National Advisory Board on Ethics in Reproduction (NABER); National Bioethics Advisory Commission